Inflammatory Bowel Disease CD4+ T Cells
About:Inflammatory Bowel Disease CD4+ T Cells are collected from IRB-consented IBD donors. Ideal for investigating helper T cell-mediated mucosal inflammation.
About Inflammatory Bowel Disease CD4+ T Cells
Inflammatory Bowel Disease CD4+ T Cells for Autoimmune and Immunopathology Research
Inflammatory Bowel Disease (IBD) CD4+ T Cells are cryopreserved from peripheral blood of IRB-consented adult donors diagnosed with Inflammatory Bowel Disease. These CD4+ helper T cells reflect disease-associated immune alterations and offer a critical resource for studying Th1/Th17 skewing, cytokine production, and mucosal inflammation in the context of IBD.
Product Features
- Research Use Only (RUO), CD4+ enriched helper T cells
- Isolated from clinically diagnosed IBD donors
- High viability and enrichment
- Cryopreserved in CryoStor® CS10 media
- Processed within 24 hours of collection
- Ethically sourced with IRB approval and HIPAA compliance
De-identified Donor Data
- Confirmed diagnosis of Inflammatory Bowel Disease
- Demographics: age, sex assigned at birth, race/ethnicity
- Self-reported clinical history and medication use
Applications
- Investigation of helper T cell phenotypes and function in IBD
- Cytokine production and mucosal immunity studies
- Disease mechanism studies and biomarker identification
- Preclinical immunotherapy development
Compliance and Quality Assurance
- IRB-approved collection and 21 CFR Part 11-compliant e-consent
- Standardized processing and quality protocols
- HIPAA-compliant data handling
Ordering & Customization
Inflammatory Bowel Disease CD4+ T Cells are offered in standard or custom aliquot sizes. For regulatory documentation or international support, contact learnmore@sanguinebio.com.
Donor Metadata
- Verified diagnosis and clinical history
- Demographic data: age, sex assigned at birth, race/ethnicity
- Medication and treatment background when available
Compliance and Quality Assurance
- IRB-approved collections and standardized procedures
- 21 CFR Part 11-compliant e-consent system
- HIPAA-compliant data management
Ordering & Customization
Human CD4+ T Cells are available in customizable aliquot sizes. For international orders or documentation needs, please contact learnmore@sanguinebio.com to confirm requirements and availability. We also work with multiple ordering platforms and distributors, learn more here.
Where can I find your complete catalog?
You can find our full product catalog here.
How long can samples be stored?
Storage depends on sample type but often cryopreserved samples stored in liquid nitrogen can be stored for years.
What customization options are available?
Extensive customization is available. To discuss your project request a quote or email us at learnmore@sanguinebio.com.
Do you offer prospective collections?
Sanguine offers flexible prospective collection services tailored to fit your research. For more information and to request a quote, please see: our prospective biospecimen collection services page.
What is the turnaround time for custom collections?
Timelines depend on condition, sample type, and I/E criteria but we often start collection within 2 weeks of signed agreement.
Do you have samples in stock?
YES - we have in-stock inventory. You can also email us at learnmore@sanguinebio.com as we continually get new samples in our inventory.
What does unique donor mean?
Each sample from a different individual - Unique donor means each sample comes from a different person, ensuring biological diversity in your study.
Are samples collected under IRB-approved protocols?
YES - "IRB-approved collection protocols" and IRB approval documentation available upon request. Sanguine utilizes two internationally-recognized IRBs (Advarra and WCG IRB) for review and approval.
Frequently Asked Questions
Ask a Question
Pair with a Healthy Control
Match your Inflammatory Bowel Disease CD4+ T Cells with normal donor samples for comparison
Healthy CD4+ T Cells
9 In Stock View InventoryNeed a custom CD4+ T Cells cohort?
Our scientific team can scope prospective collections with donor-specific I/E criteria, typically starting within 2 weeks of agreement.